Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.
- 1 January 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 27 (1) , 39-48
- https://doi.org/10.1111/j.1365-2125.1989.tb05333.x
Abstract
1. In a cross‐over study a new low molecular weight heparinoid Org 10172 was administered to 12 elderly male and female volunteers. It was well tolerated and no adverse effects occurred. 2. The absolute bioavailability of Org 10172 as measured by plasma anti‐Xa activity, glycosaminoglycuronans with no affinity to antithrombin III (NoA‐GAG) and thrombin generation inhibiting activity approached 100% in both sexes. 3. The half‐life of elimination of its anti‐Xa activity (19.2 +/‐ 6.1 h) was similar to that found previously in young volunteers. Org 10172 was further characterised by a rapid disappearance from the circulation of its anti‐thrombin activity (t1/2 1.8 +/‐ 0.6 h) and of the NoA‐GAG (t1/2 3.5 +/‐ 2.1 h). 4. Its thrombin generation inhibiting activity was of intermediate duration (t1/2 elimination 6.2 +/‐ 4.0 h).This publication has 18 references indexed in Scilit:
- USE OF ORG 10172 IN THE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSISAustralian and New Zealand Journal of Medicine, 1986
- Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic diseaseAnnals of Neurology, 1984
- TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOSIS BY NEW HEPARINOIDThe Lancet, 1983
- USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONSThe Lancet, 1983
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Anticoagulant Activities of High and Low Molecular Weight Heparin FractionsBritish Journal of Haematology, 1979
- Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)Thrombosis Research, 1978
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- EFFICACY OF LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MAJOR SURGERYThe Lancet, 1972